Clinical trial
Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile…
NCT00422578 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00422578 |
|---|---|
| Title | Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction |
| Official title | Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction (ED) Patients Previously Treated With Other Oral ED Therapy |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | ICOS Corporation Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Impotence, Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | tadalafil |
| Enrollment | 200 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Jan 17, 2007 |
| Last update posted | Oct 25, 2007 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: